Literature DB >> 28689691

Variability of homozygous sickle cell disease: The role of alpha and beta globin chain variation and other factors.

Graham R Serjeant1, Elliott Vichinsky2.   

Abstract

The single base molecular substitution characterizing sickle cell haemoglobin, β6glu→val, might be expected to result in predictable haematological and clinical features. However, the disease manifests remarkable diversity believed to reflect the interaction with other genetic and environmental factors. Some of the genetic modifiers include the beta globin haplotypes, alpha thalassaemia, factors influencing the persistence of fetal haemoglobin and the effects of the environment are addressed in this review. It is concluded that much of the genetic data present conflicting results. Environmental factors such as climate and infections, and psychological, educational and social support mechanisms also influence expression of the disease. These interactions illustrate how the expression of a 'single gene' disorder may be influenced by a variety of other genetic and environmental factors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha thalassaemia; Beta globin haplotypes; Environmental factors; Fetal haemoglobin; Sickle cell disease

Mesh:

Substances:

Year:  2017        PMID: 28689691     DOI: 10.1016/j.bcmd.2017.06.004

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  12 in total

1.  Review of Medication Therapy for the Prevention of Sickle Cell Crisis.

Authors:  Tanya R Riley; Angelo Boss; Dominique McClain; Treavor T Riley
Journal:  P T       Date:  2018-07

2.  End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.

Authors:  Ann T Farrell; Julie Panepinto; C Patrick Carroll; Deepika S Darbari; Ankit A Desai; Allison A King; Robert J Adams; Tabitha D Barber; Amanda M Brandow; Michael R DeBaun; Manus J Donahue; Kalpna Gupta; Jane S Hankins; Michelle Kameka; Fenella J Kirkham; Harvey Luksenburg; Shirley Miller; Patricia Ann Oneal; David C Rees; Rosanna Setse; Vivien A Sheehan; John Strouse; Cheryl L Stucky; Ellen M Werner; John C Wood; William T Zempsky
Journal:  Blood Adv       Date:  2019-12-10

3.  Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.

Authors:  Giulia Pavani; Anna Fabiano; Marine Laurent; Fatima Amor; Erika Cantelli; Anne Chalumeau; Giulia Maule; Alexandra Tachtsidi; Jean-Paul Concordet; Anna Cereseto; Fulvio Mavilio; Giuliana Ferrari; Annarita Miccio; Mario Amendola
Journal:  Blood Adv       Date:  2021-03-09

Review 4.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

Review 5.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

6.  Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease.

Authors:  Laura M Raffield; Jacob C Ulirsch; Rakhi P Naik; Samuel Lessard; Robert E Handsaker; Deepti Jain; Hyun M Kang; Nathan Pankratz; Paul L Auer; Erik L Bao; Joshua D Smith; Leslie A Lange; Ethan M Lange; Yun Li; Timothy A Thornton; Bessie A Young; Goncalo R Abecasis; Cathy C Laurie; Deborah A Nickerson; Steven A McCarroll; Adolfo Correa; James G Wilson; Guillaume Lettre; Vijay G Sankaran; Alex P Reiner
Journal:  PLoS Genet       Date:  2018-03-28       Impact factor: 5.917

7.  Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC).

Authors:  Caroline Conceição da Guarda; Sètondji Cocou Modeste Alexandre Yahouédéhou; Rayra Pereira Santiago; Joelma Santana Dos Santos Neres; Camila Felix de Lima Fernandes; Milena Magalhães Aleluia; Camylla Vilas Boas Figueiredo; Luciana Magalhães Fiuza; Suellen Pinheiro Carvalho; Rodrigo Mota de Oliveira; Cleverson Alves Fonseca; Uche Samuel Ndidi; Valma Maria Lopes Nascimento; Larissa Carneiro Rocha; Marilda Souza Goncalves
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

8.  Association between haematological parameters and sickle cell genotypes in children with Plasmodium falciparum malaria resident in Kisumu County in Western Kenya.

Authors:  Paul Kosiyo; Walter Otieno; Jesse Gitaka; Elly O Munde; Collins Ouma
Journal:  BMC Infect Dis       Date:  2020-11-25       Impact factor: 3.090

9.  A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease.

Authors:  Evadnie Rampersaud; Guolian Kang; Lance E Palmer; Sara R Rashkin; Shuoguo Wang; Wenjian Bi; Nicole M Alberts; Doralina Anghelescu; Martha Barton; Kirby Birch; Nidal Boulos; Amanda M Brandow; Russell John Brooke; Ti-Cheng Chang; Wenan Chen; Yong Cheng; Juan Ding; John Easton; Jason R Hodges; Celeste K Kanne; Shawn Levy; Heather Mulder; Ashwin P Patel; Latika Puri; Celeste Rosencrance; Michael Rusch; Yadav Sapkota; Edgar Sioson; Akshay Sharma; Xing Tang; Andrew Thrasher; Winfred Wang; Yu Yao; Yutaka Yasui; Donald Yergeau; Jane S Hankins; Vivien A Sheehan; James R Downing; Jeremie H Estepp; Jinghui Zhang; Michael DeBaun; Gang Wu; Mitchell J Weiss
Journal:  Blood Adv       Date:  2021-07-27

Review 10.  Sickle cell disease: a review for the internist.

Authors:  Valeria Maria Pinto; Manuela Balocco; Sabrina Quintino; Gian Luca Forni
Journal:  Intern Emerg Med       Date:  2019-08-05       Impact factor: 5.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.